C. Erik Hack

528 total citations
9 papers, 414 citations indexed

About

C. Erik Hack is a scholar working on Immunology, Hematology and Surgery. According to data from OpenAlex, C. Erik Hack has authored 9 papers receiving a total of 414 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Hematology and 2 papers in Surgery. Recurrent topics in C. Erik Hack's work include Complement system in diseases (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). C. Erik Hack is often cited by papers focused on Complement system in diseases (4 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (2 papers) and Heparin-Induced Thrombocytopenia and Thrombosis (2 papers). C. Erik Hack collaborates with scholars based in Netherlands, Germany and Italy. C. Erik Hack's co-authors include Jan H. Nuijens, J. Paardekooper, W. O. Schreuder, Lambert G. Thijs, W Bronsveld, Antonio Fantoni, Angelina Felici, Franca Citarella, Barbara Pascucci and L. Eijsman and has published in prestigious journals such as The American Journal of Medicine, The Journal of Infectious Diseases and European Journal of Biochemistry.

In The Last Decade

C. Erik Hack

9 papers receiving 396 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C. Erik Hack Netherlands 9 174 119 107 93 67 9 414
F Oberling France 11 200 1.1× 85 0.7× 54 0.5× 88 0.9× 34 0.5× 50 486
Eleonora Lauri Italy 13 136 0.8× 85 0.7× 111 1.0× 134 1.4× 97 1.4× 18 675
Richard J. Pickering United States 11 255 1.5× 104 0.9× 111 1.0× 65 0.7× 37 0.6× 20 491
Felix R. Stahl Germany 13 169 1.0× 59 0.5× 42 0.4× 181 1.9× 43 0.6× 18 511
A. C. K. Chang United States 7 172 1.0× 109 0.9× 427 4.0× 203 2.2× 67 1.0× 10 738
Samuel M. Mahaffey United States 12 297 1.7× 105 0.9× 58 0.5× 127 1.4× 166 2.5× 17 716
R A Thompson United Kingdom 12 330 1.9× 68 0.6× 48 0.4× 97 1.0× 125 1.9× 29 619
G. W. Santos United States 17 146 0.8× 87 0.7× 421 3.9× 48 0.5× 54 0.8× 30 599
Amir A. Kuperman Israel 13 103 0.6× 58 0.5× 148 1.4× 54 0.6× 31 0.5× 31 463
Miguel Jiménez-Alcázar Germany 9 574 3.3× 45 0.4× 118 1.1× 84 0.9× 48 0.7× 10 803

Countries citing papers authored by C. Erik Hack

Since Specialization
Citations

This map shows the geographic impact of C. Erik Hack's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C. Erik Hack with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C. Erik Hack more than expected).

Fields of papers citing papers by C. Erik Hack

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C. Erik Hack. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C. Erik Hack. The network helps show where C. Erik Hack may publish in the future.

Co-authorship network of co-authors of C. Erik Hack

This figure shows the co-authorship network connecting the top 25 collaborators of C. Erik Hack. A scholar is included among the top collaborators of C. Erik Hack based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C. Erik Hack. C. Erik Hack is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
Zwijnenburg, Petra, Tom van der Poll, Sandrine Florquin, et al.. (2007). C1 Inhibitor Treatment Improves Host Defense in Pneumococcal Meningitis in Rats and Mice. The Journal of Infectious Diseases. 196(1). 115–123. 22 indexed citations
2.
Mierlo, Gerard J. van, et al.. (2001). The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model. International Immunopharmacology. 1(8). 1583–1595. 24 indexed citations
3.
Portielje, Johanneke E.A., Wim H.J. Kruit, A. J. M. Eerenberg, et al.. (2001). Interleukin 12 induces activation of fibrinolysis and coagulation in humans. British Journal of Haematology. 112(2). 499–505. 17 indexed citations
4.
Minnema, Monique C., Catharina Suharti, Albert T.A. Mairuhu, et al.. (2001). Activation of coagulation factor XI, without detectable contact activation in dengue haemorrhagic fever. British Journal of Haematology. 113(1). 94–99. 38 indexed citations
5.
Meijer, Catharina, Anton T. J. Tool, Hubert A. Prins, et al.. (1999). Impaired leukocyte phagocytosis in patients undergoing hemihepatectomy for liver metastases. Liver Transplantation and Surgery. 5(3). 238–245. 12 indexed citations
6.
Hack, C. Erik, et al.. (1997). ADMINISTRATION OF OKT3 AS A TWO-HOUR INFUSION ATTENUATES FIRST-DOSE SIDE EFFECTS1. Transplantation. 64(11). 1620–1623. 17 indexed citations
7.
Jansen, Piet, et al.. (1996). Specific complement inhibition with heparin-coated extracorporeal circuits. The Annals of Thoracic Surgery. 61(4). 1153–1157. 45 indexed citations
8.
Citarella, Franca, et al.. (1996). Structure/Function Analysis of Human Factor XII Using Recombinant Deletion Mutants. European Journal of Biochemistry. 238(1). 240–249. 69 indexed citations
9.
Hack, C. Erik, Jan H. Nuijens, W. O. Schreuder, et al.. (1989). Elevated plasma levels of the anaphylatoxins C3a and C4a are associated with a fatal outcome in sepsis. The American Journal of Medicine. 86(1). 20–26. 170 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026